Vesicoureteral Reflux and Innate Immune System: Physiology, Physiopathology, and Clinical Aspects
Journal of Clinical Medicine · 19.03.2023 · 12 (6) · 2380
DOI: 10.3390/jcm12062380 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.03.2023. Verfasst von Marius-Cosmin Colceriu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Biosciences, Discipline of Physiology, Iuliu Haţieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vesicoureteral reflux represents one of the most concerning topics in pediatric nephrology due to its frequency, clinical expression with the potential to evolve into chronic kidney disease, and last but not least, its socio-economic implications. The presence of vesicoureteral reflux, the occurrence of urinary tract infections, and the development of reflux nephropathy, hypertension, chronic kidney disease, and finally, end-stage renal disease represent a progressive spectrum of a single physiopathological condition. For the proper management of these patients with the best clinical outcomes, and in an attempt to prevent the spread of uropathogens’ resistance to antibacterial therapy, we must better understand the physiopathology of urinary tract infections in patients with vesicoureteral reflux, and at the same time, we should acknowledge the implication and response of the innate immune system in this progressive pathological condition. The present paper focuses on theoretical aspects regarding the physiopathology of vesicoureteral reflux and the interconditionality between urinary tract infections and the innate immune system. In addition, we detailed aspects regarding cytokines, interleukins, antimicrobial peptides, and proteins involved in the innate immune response as well as their implications in the physiopathology of reflux nephropathy. New directions of study should focus on using these innate immune system effectors as diagnostic and therapeutic tools in renal pathology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Functional Biosciences, Discipline of Physiology, Iuliu Haţieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
- Department of Community Medicine, Discipline of Public Health and Management, Iuliu Haţieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
- Department of Mother and Child, Discipline of Pediatrics II, Iuliu Haţieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
- Nanomedicine Department, Regional Institute of Gastroenterology and Hepatology, 400158 Cluj-Napoca, Romania.
ORCID-Profile: Marius-Cosmin Colceriu, Simona Clichici
Zitieren
APA
Colceriu, M. C., Aldea, P. L., Răchișan, A. L., Clichici, S., Sevastre-Berghian, A., & Mocan, T. (2023). Vesicoureteral Reflux and Innate Immune System: Physiology, Physiopathology, and Clinical Aspects. Journal of Clinical Medicine, 12(6), 2380. https://doi.org/10.3390/jcm12062380
Vancouver
Colceriu MC, Aldea PL, Răchișan AL, Clichici S, Sevastre-Berghian A, Mocan T. Vesicoureteral Reflux and Innate Immune System: Physiology, Physiopathology, and Clinical Aspects. Journal of Clinical Medicine. 2023;12(6):2380. doi:10.3390/jcm12062380
BibTeX
@article{Colceriu2023,
author = {Colceriu, Marius-Cosmin and Aldea, Paul Luchian and Răchișan, Andreea-Liana and Clichici, Simona and Sevastre-Berghian, Alexandra and Mocan, Teodora},
title = {Vesicoureteral Reflux and Innate Immune System: Physiology, Physiopathology, and Clinical Aspects},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {6},
pages = {2380},
doi = {10.3390/jcm12062380}
}
EUVIMED